Best Stocks Under $3 Right Now It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $3.00 (3 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts. OverviewStocks Under $0.05Stocks Under $0.10Stocks Under $0.25Stocks Under $0.50Stocks Under $1Stocks Under $2Stocks Under $3Stocks Under $5Stocks Under $10Stocks Under $20Stocks Under $30Stocks Under $50Stocks On Sale 1. TuHURA Biosciences NASDAQ:HURA$2.58 +0.15 (+6.17%) Closing price 04:00 PM EasternExtended Trading$2.54 -0.04 (-1.36%) As of 06:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TuHURA Biosciences, Inc (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. More about TuHURA BiosciencesMarket Capitalization$129.12 millionConsensus RatingBuyConsensus Price Target$12.67 (+391.0% Upside)Volume209,870 sharesAverage Volume300,874 sharesToday's Range$2.45▼$2.64 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. 2. Senseonics NYSE:SENS$0.46 +0.01 (+1.74%) Closing price 04:00 PM EasternExtended Trading$0.46 +0.00 (+0.81%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. More about SenseonicsMarket Capitalization$370.92 millionP/E Ratio-3.50Consensus RatingBuyConsensus Price Target$1.54 (+237.7% Upside)Volume6.49 million sharesAverage Volume7.91 million shares3. Western Copper & Gold NYSE:WRN$1.66 0.00 (0.00%) As of 04:00 PM EasternWestern Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & GoldMarket Capitalization$334.74 millionP/E Ratio-83.00Consensus RatingBuyConsensus Price Target$4.00 (+141.0% Upside)Volume486,628 sharesAverage Volume390,614 shares4. Climb Bio NASDAQ:CLYM$2.24 +0.12 (+5.66%) As of 04:00 PM EasternClimb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. More about Climb BioMarket Capitalization$151.78 millionP/E Ratio-3.20Consensus RatingBuyConsensus Price Target$9.00 (+301.8% Upside)Volume361,778 sharesAverage Volume362,789 shares5. Mereo BioPharma Group NASDAQ:MREO$1.77 +0.04 (+2.31%) Closing price 04:00 PM EasternExtended Trading$1.78 +0.00 (+0.28%) As of 06:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom, the United States, and internationally. More about Mereo BioPharma GroupMarket Capitalization$281.43 millionP/E Ratio-25.29Consensus RatingBuyConsensus Price Target$7.40 (+318.1% Upside)Volume1.35 million sharesAverage Volume1.66 million shares6. zSpace NASDAQ:ZSPC$1.63 -0.05 (-2.98%) As of 04:00 PM EasternzSpace Technologies, Inc is a provider of commercial augmented reality and virtual reality technology principally in the education market. More about zSpaceMarket Capitalization$39.19 millionConsensus RatingBuyConsensus Price Target$10.00 (+513.5% Upside)Volume88,717 sharesAverage Volume75,578 sharesToday's Range$1.63▼$1.747. Plus Therapeutics NASDAQ:PSTV$0.43 +0.01 (+3.48%) Closing price 04:00 PM EasternExtended Trading$0.43 0.00 (-0.95%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Plus Therapeutics, Inc, a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. More about Plus TherapeuticsMarket Capitalization$42.79 millionP/E Ratio-0.19Consensus RatingBuyConsensus Price Target$7.88 (+1,726.7% Upside)Volume8.25 million sharesAverage Volume18.06 million shares8. Medicus Pharma NASDAQ:MDCX$2.43 +0.02 (+0.83%) As of 04:00 PM EasternMedicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. More about Medicus PharmaMarket Capitalization$43.30 millionP/E Ratio-1.81Consensus RatingBuyConsensus Price Target$23.50 (+867.1% Upside)Volume298,484 sharesAverage Volume238,645 shares9. CytomX Therapeutics NASDAQ:CTMX$2.04 +0.11 (+5.70%) Closing price 04:00 PM EasternExtended Trading$1.99 -0.05 (-2.45%) As of 06:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.CytomX Therapeutics, Inc, an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. More about CytomX TherapeuticsMarket Capitalization$336.42 millionP/E Ratio3.64Consensus RatingBuyConsensus Price Target$5.30 (+159.8% Upside)Volume3.91 million sharesAverage Volume3.21 million shares10. SAB Biotherapeutics NASDAQ:SABS$2.79 +0.21 (+8.14%) Closing price 04:00 PM EasternExtended Trading$2.80 +0.02 (+0.54%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.SAB Biotherapeutics, Inc, a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases. More about SAB BiotherapeuticsMarket Capitalization$29.04 millionP/E Ratio-0.70Consensus RatingBuyConsensus Price Target$9.75 (+249.5% Upside)Volume785,754 sharesAverage Volume570,906 shares11. ImmunityBio NASDAQ:IBRX$2.85 +0.09 (+3.26%) Closing price 04:00 PM EasternExtended Trading$2.84 0.00 (-0.18%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ImmunityBio, Inc, a clinical-stage biotechnology company, engages in developing therapies and vaccines that bolster the natural immune system to defeat cancers and infectious diseases. More about ImmunityBioMarket Capitalization$2.69 billionP/E Ratio-5.94Consensus RatingBuyConsensus Price Target$10.75 (+277.2% Upside)Volume10.78 million sharesAverage Volume8.13 million shares12. Stardust Power NASDAQ:SDST$2.85 -0.05 (-1.72%) Closing price 04:00 PM EasternExtended Trading$2.84 0.00 (-0.18%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.Market Capitalization$24.11 millionP/E Ratio-0.51Consensus RatingBuyConsensus Price Target$51.13 (+1,693.9% Upside)Volume135,272 sharesAverage Volume407,670 shares13. Ur Energy NYSEAMERICAN:URG$1.51 +0.02 (+1.34%) Closing price 04:10 PM EasternExtended Trading$1.51 0.00 (0.00%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur EnergyMarket Capitalization$550.89 millionP/E Ratio-8.88Consensus RatingBuyConsensus Price Target$2.48 (+63.9% Upside)Volume7.71 million sharesAverage Volume5.53 million shares14. Quince Therapeutics NASDAQ:QNCX$1.61 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$1.62 +0.01 (+0.93%) As of 06:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince TherapeuticsMarket Capitalization$86.47 millionP/E Ratio-1.48Consensus RatingBuyConsensus Price Target$8.14 (+405.8% Upside)Volume149,204 sharesAverage Volume226,355 shares15. Ovid Therapeutics NASDAQ:OVID$1.22 +0.06 (+5.17%) Closing price 04:00 PM EasternExtended Trading$1.20 -0.02 (-2.05%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid TherapeuticsMarket Capitalization$86.75 millionP/E Ratio-2.30Consensus RatingBuyConsensus Price Target$3.10 (+154.1% Upside)Volume1.07 million sharesAverage Volume1.03 million shares16. Biomea Fusion NASDAQ:BMEA$2.08 +0.12 (+6.12%) Closing price 04:00 PM EasternExtended Trading$2.05 -0.03 (-1.44%) As of 06:39 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Biomea Fusion, Inc, a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. More about Biomea FusionMarket Capitalization$123.78 millionP/E Ratio-0.69Consensus RatingBuyConsensus Price Target$14.80 (+611.5% Upside)Volume681,415 sharesAverage Volume1.28 million shares17. OnKure Therapeutics NASDAQ:OKUR$2.48 +0.09 (+3.77%) Closing price 04:00 PM EasternExtended Trading$2.52 +0.04 (+1.41%) As of 05:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.OnKure Therapeutics, Inc engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. More about OnKure TherapeuticsMarket Capitalization$33.55 millionP/E Ratio-0.52Consensus RatingBuyConsensus Price Target$32.33 (+1,203.8% Upside)Volume17,770 sharesAverage Volume106,594 shares18. Context Therapeutics NASDAQ:CNTX$1.00 +0.13 (+14.29%) Closing price 04:00 PM EasternExtended Trading$0.98 -0.02 (-1.50%) As of 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context TherapeuticsMarket Capitalization$89.70 millionP/E Ratio-2.78Consensus RatingBuyConsensus Price Target$5.20 (+420.0% Upside)Volume638,325 sharesAverage Volume193,604 shares19. Reviva Pharmaceuticals NASDAQ:RVPH$0.42 +0.02 (+3.73%) Closing price 04:00 PM EasternExtended Trading$0.32 -0.10 (-23.94%) As of 06:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva PharmaceuticalsMarket Capitalization$28.52 millionP/E Ratio-0.65Consensus RatingBuyConsensus Price Target$5.50 (+1,211.4% Upside)Volume3.58 million sharesAverage Volume1.67 million shares20. ProQR Therapeutics NASDAQ:PRQR$2.19 +0.13 (+6.31%) Closing price 04:00 PM EasternExtended Trading$2.12 -0.07 (-3.42%) As of 05:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR TherapeuticsMarket Capitalization$230.41 millionP/E Ratio-4.76Consensus RatingBuyConsensus Price Target$8.00 (+265.3% Upside)Volume379,866 sharesAverage Volume416,053 shares21. Denison Mine NYSEAMERICAN:DNN$2.57 +0.03 (+1.18%) Closing price 04:10 PM EasternExtended Trading$2.58 +0.01 (+0.19%) As of 06:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison MineMarket Capitalization$2.30 billionP/E Ratio-42.83Consensus RatingBuyConsensus Price Target$3.00 (+16.7% Upside)Volume59.52 million sharesAverage Volume76.70 million shares22. Aclaris Therapeutics NASDAQ:ACRS$1.95 +0.14 (+7.73%) Closing price 04:00 PM EasternExtended Trading$1.94 0.00 (-0.26%) As of 05:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris TherapeuticsMarket Capitalization$211.25 millionP/E Ratio-1.42Consensus RatingBuyConsensus Price Target$8.71 (+346.9% Upside)Volume1.04 million sharesAverage Volume966,791 shares23. Acrivon Therapeutics NASDAQ:ACRV$1.67 +0.11 (+7.05%) Closing price 04:00 PM EasternExtended Trading$1.68 +0.01 (+0.30%) As of 06:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Acrivon Therapeutics, Inc, a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. More about Acrivon TherapeuticsMarket Capitalization$52.53 millionP/E Ratio-0.74Consensus RatingBuyConsensus Price Target$15.00 (+798.2% Upside)Volume356,378 sharesAverage Volume760,424 shares24. Gain Therapeutics NASDAQ:GANX$1.70 +0.12 (+7.59%) Closing price 04:00 PM EasternExtended Trading$1.72 +0.02 (+0.88%) As of 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain TherapeuticsMarket Capitalization$61.12 millionP/E Ratio-2.70Consensus RatingBuyConsensus Price Target$8.00 (+370.6% Upside)Volume985,996 sharesAverage Volume311,884 shares25. TScan Therapeutics NASDAQ:TCRX$1.72 +0.12 (+7.50%) Closing price 04:00 PM EasternExtended Trading$1.72 0.00 (0.00%) As of 06:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.TScan Therapeutics, Inc, a clinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. More about TScan TherapeuticsMarket Capitalization$97.61 millionP/E Ratio-1.58Consensus RatingBuyConsensus Price Target$7.80 (+353.5% Upside)Volume310,096 sharesAverage Volume439,552 shares More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The Fed Cut Rates: What Now for the S&P 500 and Equity Markets? Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything Bloom Energy Booms on AI Power Demand and Analyst Upgrades Can Apple’s iPhone 17 and AI Push Its Stock to New Highs? New Catalysts Build Positive Pressure on Intel Stock Oracle to Hit $1 Trillion Valuation in 2025: Here’s Why General Mills Is a Generational Opportunity for Income Investors Nike’s Red-Hot Analyst Buzz: Is a Comeback Brewing? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
